| scholarly article | Q13442814 |
| P50 | author | Peter Garred | Q59433407 |
| Stephen Spellman | Q111077182 | ||
| P2093 | author name string | T Wang | |
| X Zhu | |||
| C Müller | |||
| S J Lee | |||
| J S Johansen | |||
| K Müller | |||
| K Fleischhauer | |||
| B Kornblit | |||
| M R Verneris | |||
| L Vindelov | |||
| P2860 | cites work | Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway | Q24298961 |
| IL-6, but not TNF-α, increases plasma YKL-40 in human subjects | Q24299238 | ||
| Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family | Q24319994 | ||
| YKL-40 is elevated in cerebrospinal fluid from patients with purulent meningitis | Q24531928 | ||
| Nonparametric Estimation from Incomplete Observations | Q25938997 | ||
| gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells | Q28178254 | ||
| YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis | Q28262081 | ||
| Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells | Q33255102 | ||
| Estimation of failure probabilities in the presence of competing risks: new representations of old estimators | Q33594562 | ||
| A chitinase-like protein in the lung and circulation of patients with severe asthma | Q34713773 | ||
| Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). | Q34749292 | ||
| ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation | Q35187185 | ||
| Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer | Q36646351 | ||
| Role of mammalian chitinases in inflammatory conditions | Q36773328 | ||
| Serum YKL-40 and interleukin 6 levels in Hodgkin lymphoma | Q37036167 | ||
| Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis | Q37273123 | ||
| Plasma YKL-40: a potential new cancer biomarker? | Q37605869 | ||
| Selection of adult unrelated hematopoietic stem cell donors: beyond HLA. | Q37627993 | ||
| Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. | Q37807414 | ||
| YKL-40 acts as an angiogenic factor to promote tumor angiogenesis | Q41073254 | ||
| High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection | Q43864376 | ||
| Stability of YKL-40 concentration in blood samples | Q43949834 | ||
| Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation. | Q44559401 | ||
| Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome | Q47359749 | ||
| IL-13 production by donor T cells is prognostic of acute graft-versus-host disease following unrelated donor stem cell transplantation | Q47602546 | ||
| YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils | Q47756516 | ||
| Influence of donor/recipient sex matching on outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia. | Q51794738 | ||
| Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. | Q52176115 | ||
| Serum YKL-40 levels in patients with coronary artery disease. | Q53541124 | ||
| Circulating tumor necrosis factor-α and YKL-40 level is associated with remission status following salvage therapy in relapsed non-Hodgkin lymphoma. | Q53651858 | ||
| The Prognostic Value of YKL-40 Concentrations in Nonmyeloablative Conditioning Allogeneic Hematopoietic Cell Transplantation | Q63728028 | ||
| Plasma IL‐6, plasma VEGF, and serum YKL‐40: relationship with disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab and methotrexate | Q63753511 | ||
| Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors | Q70051817 | ||
| Serum YKL-40 is increased in patients with hepatic fibrosis | Q74012591 | ||
| High serum concentration of YKL-40 is associated with short survival in patients with acute myeloid leukemia | Q81639135 | ||
| Plasma YKL-40 levels in healthy subjects from the general population | Q83311830 | ||
| YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma | Q83578684 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Chitinase 3 like 1 | Q21117210 |
| P304 | page(s) | 1556-1560 | |
| P577 | publication date | 2016-07-18 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | YKL-40 in allogeneic hematopoietic cell transplantation after AML and myelodysplastic syndrome | |
| P478 | volume | 51 |
| Q92497923 | Stress responses, M2 macrophages, and a distinct microbial signature in fatal intestinal acute graft-versus-host disease | cites work | P2860 |
Search more.